Polio vaccines are inexpensive, easily available, already approved—and they might work wonders against COVID-19

x
Credit: Ezra Ecayan

Recent reports indicate that COVID-19 may result in suppressed innate immune responses. Therefore, stimulation by live attenuated vaccines [such as the polio vaccine] could increase resistance to infection by the causal virus, severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2). Clinical studies of this hypothesis could begin immediately. [Tuberculosis vaccine] trials have already been initiated by immunizing frontline health care workers. The endpoint of these trials is the difference in COVID-19 incidence, duration, and severity between immunized and unimmunized populations.

We propose the use of OPV to ameliorate or prevent COVID-19. Both poliovirus and coronavirus are positive-strand RNA viruses; therefore, it is likely that they may induce and be affected by common innate immunity mechanisms. There are multiple important advantages to using OPV: a strong safety record, the existence of more than one serotype that could be used sequentially to prolong protection, low cost, ease of administration, and availability. Over 1 billion doses of OPV are produced and used annually in more than 140 countries. Although the supply of BCG is limited, a small fraction of OPV intended for the suspended polio eradication campaign would be sufficient for the clinical trials, and provided a positive outcome, production could likely be scaled up quickly.

If proven to be effective against COVID-19, emergency immunization with live attenuated vaccines could be used for protection against other unrelated emerging pathogens.

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.